Current Headlines

  1. Stem Cell Treatment Speeds Up Recovery after Spinal Cord Injury in Monkeys
  2. New drug discovery company announces $4m Series-A funding to tackle chronic respiratory disease

    ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing.

  3. EMD Millipore Introduces Single-Pass Tangential Flow Filtration With Pellicon Cassettes For Increased Capacity, Recovery And Concentration

    EMD Millipore, the Life Science business ofMerck KGaA of Darmstadt, Germany, recently introduced single-pass tangential flow filtration (TFF) with Pellicon cassettes, an enhanced application of EMD Millipore's existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.

  4. Global Vision Announces The Release Of DocuProof 3.1.0
  5. Reducing Protocol Time For 96-Well PCR Assays

    The virus and prion validation group at Octapharma GmbH (Frankfurt, Germany) reports how implementing an INTEGRA VIAFLO 96 has enabled them to reduce the time taken to undertake PCR assays by greater than 60%.

  6. Pfizer Acquires Minority Interest In AM-Pharma; Secures Option To Acquire Company

    AM-Pharma B.V., a privately held Dutch biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase (recAP ) for inflammatory diseases, and Pfizer Inc. announced recently that Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company.

  7. Goodwin Biotechnology Was Selected By Panacea Pharmaceuticals For A Highly Specialized Vaccine Fill / Finish Project

    Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization (CDMO) that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β‐Hydroxylase (HAAH) tumor‐specific protein to support Phase I clinical trials in patients with various solid tumor cancers.

  8. The Industry’s First Portable Cryogenic Biospecimen Handling And Transport System With Integrated Real-Time Temperature Monitoring

    BioCision, LLC, a leader in advanced biomaterial sample handling and standardization tools, and Brooks Automation, a global provider of automated sample storage systems for compound management and biorepositories, today announced the launch of CryoPod™ Carrier, a jointly developed liquid nitrogen (LN2)-based system for the safe, reliable and protected handling and transport of cryogenic biospecimens. 

  9. New Research-Based Pharmaceutical Industry Report Provides Insights On How To Slow Down Antimicrobial Resistance (AMR) And Boost Antibiotic R&D

    The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) released recently a new report on antimicrobial resistance (AMR) calling for a global coordinated, multi-faceted policy approach to minimize the growth of resistance, highlighting the scientific challenges associated with the development of new antibiotics and the need for economic incentives to ensure sustainable investments in antibacterial research and development.

  10. AVT And Global Vision Collaborate To Offer Cutting-Edge Offline Inspection Solutions For Printing Industry

    AVT, the world leader in print inspection, print process control, and quality assurance, is joining forces with leading proofing solutions provider Global Vision to offer advanced offline inspection solutions to the worldwide printing market.

Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.